-
successful candidate, you will be: Developing liquid biopsy biomarkers for cancer diagnosis, prognosis, and therapy response prediction. Investigating the epigenetic basis of GI cancers, such as aberrant DNA
-
radiation that can be targeted to enhance anti-tumor immunity and/or minimize normal tissue toxicity for gastrointestinal (GI) malignancies. In addition, we have discovered a novel immune-mediated mechanism
-
immunologic pathways activated by radiation that can be targeted to enhance anti-tumor immunity and/or minimize normal tissue toxicity for gastrointestinal (GI) malignancies. In addition, we have discovered a
-
and epigenomic characterization of various gastrointestinal cancers (GI) including colorectal, pancreatic and gastric cancers, and some of the key research topics include: 1) Development of circulating
-
to genomic and epigenomic characterization of various gastrointestinal cancers (GI) including colorectal, pancreatic and gastric cancers, and some of the key research topics include: 1) Development
-
prediction. Investigating the epigenetic basis of GI cancers, such as aberrant DNA methylation, histone modifications, and non-coding RNAs. Exploring the genetics of early-onset and familial/hereditary